You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SDX-105

Showing 1 - 25 of 252
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CCND1 Positive, Mantle Cell Lymphoma, t(11;14) Positive Trial in Atlanta, Johns Creek (Bendamustine, Obinutuzumab, Venetoclax)

Active, not recruiting
  • CCND1 Positive
  • +2 more
  • Atlanta, Georgia
  • +2 more
Nov 2, 2022

Non-Hodgkin's Lymphoma Trial in Philadelphia (drug, procedure, genetic)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Sep 14, 2022

Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,

Not yet recruiting
  • Prostate Carcinoma
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 17, 2023

Metastatic Colorectal Adenocarcinoma, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

Not yet recruiting
  • Metastatic Colorectal Adenocarcinoma
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 12, 2023

Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma Trial (procedure, drug, biological, radiation, other)

Not yet recruiting
  • Recurrent Classic Hodgkin Lymphoma
  • Refractory Classic Hodgkin Lymphoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +13 more
  • (no location specified)
Feb 2, 2023

Hematopoietic and Lymphoid System Tumor Trial in Houston (procedure, drug, biological, radiation)

Recruiting
  • Hematopoietic and Lymphoid System Neoplasm
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 20, 2022

Follicular Lymphoma Trial in Houston (Bendamustine, Mitoxantrone, Rituximab)

Terminated
Has Results
  • Follicular Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 1, 2020

Leukemia, Lymphoma Trial in Houston (Rituximab, 111In Ibritumomab, Planar Scintigraphy Imaging)

Completed
Has Results
  • Leukemia
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 23, 2020

Chronic Lymphocytic Leukemia Trial in Houston (Lenalidomide, Fludarabine, Rituximab)

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 14, 2020

Refractory Multiple Myeloma Trial in United States (bendamustine HCl, lenalidomide, dexamethasone)

Completed
Has Results
  • Refractory Multiple Myeloma
  • bendamustine hydrochloride
  • +2 more
  • Duarte, California
  • +4 more
Feb 10, 2020

Leukemia Trial in Houston (Bendamustine, Fludarabine, Rituximab)

Completed
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 24, 2019

Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in Philadelphia (Bendamustine HCl,

Completed
Has Results
  • Stage I Multiple Myeloma
  • +2 more
  • Bendamustine hydrochloride
  • +2 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Aug 27, 2019

Idiopathic Hypersomnia Trial in United States (Serdexmethylphenidate, Placebo)

Recruiting
  • Idiopathic Hypersomnia
  • Birmingham, Alabama
  • +34 more
Dec 29, 2022

Breast Cancer, Metastatic Triple-Negative Breast Cancer Trial in United States (Eribulin, SDX-7320, Placebo)

Recruiting
  • Breast Cancer
  • Metastatic Triple-Negative Breast Cancer
  • Basking Ridge, New Jersey
  • +6 more
Oct 4, 2022

Metastatic Solid Tumors, NSCLC, Melanoma Trial in United States (INBRX-105 - PDL1x41BB antibody, Pembrolizumab)

Recruiting
  • Metastatic Solid Tumors
  • +7 more
  • Scottsdale, Arizona
  • +12 more
Jan 26, 2023

Herpes Zoster (HZ), Shingles, Infectious Disease Trial in Hollywood, Tampa, Berlin (JCXH-105, Active Control (Shingrix))

Recruiting
  • Herpes Zoster (HZ)
  • +2 more
  • JCXH-105
  • Active Control (Shingrix)
  • Hollywood, Florida
  • +2 more
May 23, 2023

CD20 Positive, Chronic Lymphocytic Leukemia, Follicular Lymphoma Trial in Houston (procedure, biological, drug)

Completed
  • CD20 Positive
  • +6 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
May 30, 2019

Healthy Volunteers Trial in Tempe, Las Vegas, Austin (TAK-105, TAK-105 Placebo)

Active, not recruiting
  • Healthy Volunteers
  • Tempe, Arizona
  • +2 more
Jul 13, 2022

Childhood-Onset Fluency Disorder Trial in Australia, United States (NOE-105, Placebo)

Recruiting
  • Childhood-Onset Fluency Disorder
  • Chino, California
  • +8 more
Jan 23, 2023

Sleep, Sleep Deprivation, Cognitive Change Trial in Boston (Nap Practitioners, Shoonya Meditation, Shukha Kriya Practice)

Recruiting
  • Sleep
  • +2 more
  • Nap Practitioners
  • +2 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Centre
Jul 14, 2022

Pain, Fear, Nurse's Role Trial in Izmir (Implementation of Bee Buzzy, Implementation of Puppet Zuzu)

Completed
  • Pain
  • +2 more
  • Implementation of Bee Buzzy
  • Implementation of Puppet Zuzu
  • İzmir, Turkey
    Bakırcay University
Apr 12, 2023

Attention Deficit/Hyperactivity Disorder Trial (Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH), )

Not yet recruiting
  • Attention Deficit/Hyperactivity Disorder
  • Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH)
  • placebo
  • (no location specified)
Jan 5, 2023

Solid Tumor, Adult, Non-hodgkin Lymphoma, Hodgkin Lymphoma Trial in India (AUR105)

Recruiting
  • Solid Tumor, Adult
  • +2 more
  • Vadodara, Gujarat, India
  • +6 more
Dec 14, 2022

Heart Failure With Preserved Ejection Fraction, Concentric Hypertrophy Trial (Pacemaker PLR + TRT ON, Pacemaker PLR ON)

Not yet recruiting
  • Heart Failure With Preserved Ejection Fraction
  • Concentric Hypertrophy
  • Pacemaker PLR + TRT ON
  • Pacemaker PLR ON
  • (no location specified)
Apr 20, 2023

Metabolic Syndrome Trial in Québec (INV-202, Placebo)

Completed
  • Metabolic Syndrome
  • Québec, Quebec, Canada
    Syneos Health Clinique Inc
Oct 3, 2022